retatrutide lilly As an obesity medicine physician, I don't get surprised very often anymore. This surprised me. In Eli Lilly's Phase 3 TRIUMPH-1 trial, the highest dose of produced an average of 28.3% Eli Lilly's retatrutide hits Phase

Nutritional deficiencies such as iron deficiency anaemia, which can develop during significant dietary restriction, may also contribute

Retatrutide is at least 18 months away from MHRA approval, and probably longer before its available on the NHS

Tirzepatide Retatrutide is often compared with semaglutide and tirzepatide because all three belong to the broader incretin-based treatment conversation

NEW RESEARCH LAB DISCUSSION, CONNECTING MULTI RECEPTOR SIGNALING TO DOWNSTREAM READOUTS Laboratories increasingly design experiments that move beyond single receptor readouts to integrated readout stacks that connect receptor activity to downstream cellular programs